Filed before 2025Filed 27 June 2022
Neurolens, Inc. has sold $14.7M so far
Neurolens, Inc., a biotech company based in Coppell, TX, has sold $14.7M so far in its debt round, according to a filing dated 27 June 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 27 June 2022
- First filed
- 17 November 2021
- Round
- Debt round (amended filing)
- Amount sold
- $14.7M
- Offering size
- $15M
- Investors so far
- 27
- Based in
- Coppell, TX
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 62% of the 1,764 tracked raises with an amount filed in 2022, and than 58% of the 142 in biotech.
Neurolens, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 13 Sep 2022 | New filing | $67.6M | Another raise |
| 27 Jun 2022 | Amended filing | $14.7M | This raise |
| 17 Nov 2021 | New filing | $12M | This raise |
| 12 Mar 2020 | Amended filing | $23.8M | Another raise |
| 16 Dec 2019 | Amended filing | $23M | Another raise |
| 7 Aug 2019 | New filing | $15.2M | Another raise |
| 27 Dec 2017 | Amended filing | $13.1M | Another raise |
More with Versant on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.